LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Densitas® et ScreenPoint Medical s’associent pour offrir de meilleurs résultats aux patients
Patient Discovery Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
Craig Hospital receives anonymous gifts to grow Neurobehavioral Rehabilitation Program
Rising Insurance Enrolments Bolster Growth
America’s Best Wings: Everything You Need to Know
A new health branch inaugurated in Marciac, the first patients received on June 13
Metaverse Beauty Week: a 100% beauty festival organized in cyberspace
Tok beauté: ‘Cherry Cola Lips’, the ultimate lipstick shade to adopt before summer
L’Isle-Jourdain: common reflection on medical desertification between elected officials and citizens
Blood donation: dogs and cats can also save lives!
ANDERNACH, Germany, June 8, 2023 /PRNewswire/ — LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such...